Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ARRY | US
0
0%
Healthcare
Biotechnology
30/06/2024
24/04/2026
8.11
8.13
8.22
7.91
Array Technologies Inc. manufactures and sells ground-mounting tracking systems used in solar energy projects in the United States Spain Brazil Australia and internationally. The company operates in two segments Array Legacy Operations and STI Operations. Its products include DuraTrack HZ v3 a single axis tracker; Array STI H250 to deliver a lower levelized cost of energy with tracker system; Array OmniTrack; and SmarTrack a software product that uses site-specific historical weather and energy production data in combination with machine learning algorithms to identify the optimal position for a solar array in real time to enhance its energy production. The company was founded in 1989 and is headquartered in Albuquerque New Mexico.
View LessHigh 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Weak P/E, and PEG ratio indicator
High Market Beta (> 0.8)
High Short percentage (> 15%)
High Debt to Equity (> 0.75)
Declining Revenue (< 0%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
51.0%1 month
65.6%3 months
90.7%6 months
84.1%68.10
7.49
5.08
1.18
0.41
9.79
1.63
0.17
158.44M
1.23B
1.23B
-
14.12
-76.80
-49.60
11.81
5.92
24.30
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.45
Range1M
1.83
Range3M
5.72
Rel. volume
0.66
Price X volume
26.44M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| immatics biotechnologies GmbH | IMTX | Biotechnology | 11.35 | 1.35B | 1.79% | n/a | 0.00% |
| Novavax Inc | NVAX | Biotechnology | 8.22 | 1.32B | 0.86% | n/a | -54.03% |
| Taysha Gene Therapies Inc | TSHA | Biotechnology | 6.4 | 1.31B | 0.00% | n/a | 53.02% |
| Capricor Therapeutics Inc | CAPR | Biotechnology | 35.27 | 1.25B | 4.16% | n/a | 45.32% |
| Monte Rosa Therapeutics Inc | GLUE | Biotechnology | 19.79 | 1.21B | -1.88% | n/a | 19.74% |
| Progenitor Inc | PGEN | Biotechnology | 4.13 | 1.21B | 4.29% | n/a | 14.69% |
| NRIX | NRIX | Biotechnology | 16.68 | 1.18B | 0.66% | n/a | 7.20% |
| AbCellera Biologics Inc | ABCL | Biotechnology | 4.15 | 1.17B | 2.47% | n/a | 6.49% |
| Pharming Group N.V. | PHAR | Biotechnology | 16.68 | 1.13B | 0.24% | n/a | 63.43% |
| Oculis Holding AG Ordinary shares | OCS | Biotechnology | 26.44 | 1.10B | -1.23% | n/a | 1.19% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 39.11 | 1.23B | -1.21% | 51.60 | 88.92% |
| Winnebago Industries Inc | WGO | Recreational Vehicles | 32.87 | 951.75M | 0.70% | 22.53 | 56.33% |
| Janus International Group Inc. | JBI | Building Products & Equipment | 5.44 | 790.55M | 1.30% | 11.62 | 116.21% |
| Fox Factory Holding Corp | FOXF | Recreational Vehicles | 17.7 | 737.79M | 2.31% | 42.05 | 64.69% |
| Latham Group Inc. | SWIM | Building Products & Equipment | 6.01 | 694.62M | -0.17% | 65.18 | 77.00% |
| Ennis Inc | EBF | Building Products & Equipment | 20.33 | 528.66M | -1.26% | 13.28 | 2.28% |
| Malibu Boats Inc | MBUU | Recreational Vehicles | 26.1 | 521.76M | -0.91% | n/a | 1.50% |
| MCBC Holdings Inc | MCFT | Recreational Vehicles | 23.53 | 390.77M | -0.88% | 34.27 | 26.82% |
| Camping World Holdings Inc | CWH | Recreational Vehicles | 7.48 | 337.57M | 8.41% | n/a | 3644.76% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 3.31 | 317.09M | 1.85% | n/a | 174.23% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 9.79 | 0.53 | Expensive |
| Ent. to Revenue | 1.63 | 3,967.00 | Cheaper |
| PE Ratio | 68.10 | 41.03 | Expensive |
| Price to Book | 5.08 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 90.73 | 72.80 | Riskier |
| Debt to Equity | 1.18 | -1.23 | Expensive |
| Debt to Assets | 0.41 | 0.25 | Expensive |
| Market Cap | 1.23B | 3.66B | Emerging |